Holen Sie sich die Stockscreener-App
4.55
2.02%
0.09
Handel nachbörslich:
4.18
-0.37
-8.13%
Advanced Biomed Inc Aktie (ADVB) Neueste Nachrichten
Advanced Biomed Inc. to Acquire Acellent Technologies (Hong Kong) in $1.08 Million All-Stock Deal - Minichart
Contrasting Advanced Biomed (NASDAQ:ADVB) and Caris Life Sciences (NASDAQ:CAI) - Defense World
Advanced Biomed to acquire Acellent Technologies in all-stock deal - Investing.com
Advanced Biomed to Acquire AI Audit Firm Acellent - TipRanks
Advanced Biomed to Acquire Acellent Technologies (Hong Kong) for $1.08 Million in Stock - TradingView
Advanced Biomed (NASDAQ: ADVB) to buy Acellent in $1.08M stock transaction - Stock Titan
If You Invested $1,000 in Inotiv Inc (NOTV) - Stock Titan
Can Advanced Biomed Inc outperform under higher oil prices2026 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Advanced Biomed Announces Leadership Changes and Board Appointment - TipRanks
Advanced Biomed (NASDAQ: ADVB) CTO exits as CFO Mingze Yin joins board - Stock Titan
Risks Report: Will Advanced Biomed Inc benefit from seasonality2026 Buyback Activity & Safe Capital Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gainers Report: Whats Advanced Biomed Incs historical return2026 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
If You Invested $1,000 in Applied Dna Scie (APDN) - Stock Titan
Advanced Biomed to implement 1-for-20 reverse stock split to meet Nasdaq requirement - MSN
Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com
Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Barchart
Glioma Pipeline Expands As 180+ Pharma Companies Advance Several Novel Therapies, Finds Delveinsight Aivita Biomedical, Denovo Biopharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Mena FN
These stocks that are showing activity before the opening bell on Tuesday. - chartmill.com
Tech Rally: Should I hold or sell Advanced Biomed Inc nowInflation Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
Advanced Biomed (NASDAQ: ADVB) preserves Nasdaq listing after reverse split restores $1 bid - Stock Titan
Aug Gainers: Whats the fair value of Advanced Biomed Inc stock2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
Market Leaders: Whats the fair value of Advanced Biomed Inc stock2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Catalysts: Is Advanced Biomed Inc currently under institutional pressure2026 PreEarnings & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Dip Buying: What hedge funds are buying ProShares Trust ProShares Ultra FTSE EuropeJuly 2025 PreEarnings & Smart Money Movement Alerts - baoquankhu1.vn
Rally Mode: Should I hold or sell Advanced Biomed Inc nowDividend Hike & Low Risk Entry Point Guides - baoquankhu1.vn
Growth Report: Will JPMPRL benefit from government policyJuly 2025 Macro Moves & AI Enhanced Trading Alerts - baoquankhu1.vn
Aug Summary: Is Advanced Biomed Inc a strong candidate for buy and holdWeekly Profit Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Morning Market Movers: ALTO, GO, TTD, VCIG See Big Swings - RTTNews
Risk On: Should value investors consider ACXPJuly 2025 Short Interest & Long Hold Capital Preservation Plans - baoquankhu1.vn
Surge for ADVB: New Partnerships and Market Strategies Drive Momentum - timothysykes.com
Advanced Biomed Executes Reverse Split to Maintain Nasdaq Listing - TipRanks
Advanced Biomed (NASDAQ: ADVB) completes 1-for-20 reverse stock split - Stock Titan
Volume Report: Is Columbus Acquisition Corp Debt Equity Composite Units stock a good pick for beginnersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Sentiment Review: Does GROY have strong fundamentalsPortfolio Update Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
BioMed Realty and Babraham Research Campus Ltd Complete Lease-Up of Newest Building at Babraham Research Campus, with TRIMTECH Therapeutics and Tagomics - Business Wire
How Advanced Biomed Inc. stock performs during Fed tightening cyclesWeekly Trading Summary & Expert Approved Trade Ideas - mfd.ru
Head-To-Head Contrast: Billiontoone (NASDAQ:BLLN) and Advanced Biomed (NASDAQ:ADVB) - Defense World
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance By Investing.com - Investing.com South Africa
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation - 富途牛牛
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance - Investing.com Canada
Uber to invest over $100 million in autonomous vehicle charging amid robotaxi push - Bitget
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer - Bitget
Advanced Biomed Inc. Announces 1-for-20 Reverse Stock Split Effective February 20, 2026 - Quiver Quantitative
Advanced Biomed Inc. announces 1 for 20 share consolidation - marketscreener.com
Advanced Biomed Inc. Announces 1 For 20 Share Consolidation - TradingView
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Will Advanced Biomed Inc. stock deliver better than expected guidanceJuly 2025 Trade Ideas & Safe Swing Trade Setups - mfd.ru
Advanced Biomed Inc. SEC 10-Q Report - TradingView
Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusCIntegrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - The Manila Times
Nasus Pharma Announces Closing of $15.0 Million Private Placement - Bitget
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):